Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 5.84bn | 5.34bn | 5.32bn | 4.72bn | 4.38bn | 4.17bn |
| Cost of revenue | — | — | — | 2.41bn | 2.30bn | 2.17bn |
| Gross profit | 2.91bn | 2.65bn | 2.68bn | 2.31bn | 2.07bn | 2.00bn |
| Research and development | 583m | 573m | 576m | 526m | 495m | 495m |
| Selling, general and administrative | 280m | 268m | 279m | 226m | 244m | 243m |
| Operating expenses | 864m | 841m | 856m | 752m | 739m | 738m |
| Operating income | 2.05bn | 1.81bn | 1.83bn | 1.56bn | 1.33bn | 1.26bn |
| Pre-tax income | 2.01bn | 1.84bn | 1.86bn | 1.54bn | 1.35bn | 1.29bn |
| Income tax | 186m | 243m | 291m | 206m | 157m | 178m |
| Net income | 1.83bn | 1.59bn | 1.57bn | 1.33bn | 1.19bn | 1.12bn |
| Earnings per share | 1.46 | 1.27 | 1.24 | 1.04 | 0.93 | 0.86 |
| Earnings per share, diluted | 1.45 | 1.26 | 1.24 | 1.03 | 0.92 | 0.86 |
| Weighted average shares | 1.25bn | 1.25bn | 1.26bn | 1.28bn | 1.29bn | 1.30bn |
| Weighted average shares, diluted | 1.26bn | 1.26bn | 1.27bn | 1.29bn | 1.29bn | 1.30bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.75bn | 6.18bn | 6.69bn | 6.39bn | 5.45bn | 5.67bn | 6.07bn | 5.85bn |
| Receivables | 4.13bn | 3.49bn | 3.63bn |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 1.78bn | — | — | 1.57bn |
| Depreciation and amortisation | — | — | 102m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 3.38bn |
| 3.23bn |
| 3.30bn |
| 2.94bn |
| 2.52bn |
| Inventory | 4.00bn | 4.04bn | 4.10bn | 4.31bn | 4.46bn | 4.36bn | 4.21bn | 4.22bn |
| Current assets | 13.30bn | 14.02bn | 14.81bn | 14.52bn | 13.46bn | 13.61bn | 13.49bn | 12.88bn |
| Goodwill | — | — | — | — | — | — | — | 1.63bn |
| Total assets | 20.79bn | 21.39bn | 21.90bn | 21.35bn | 19.97bn | 19.84bn | 19.53bn | 18.74bn |
| Current liabilities | 5.24bn | 6.21bn | 6.71bn | 6.57bn | 5.49bn | 5.35bn | 5.34bn | 4.34bn |
| Long-term debt | 3.73bn | 3.73bn | 3.73bn | 3.73bn | 3.73bn | 4.48bn | 4.48bn | 4.48bn |
| Total liabilities | 10.21bn | 11.25bn | 11.71bn | 11.48bn | 10.46bn | 11.03bn | 11.06bn | 10.21bn |
| Equity | 10.58bn | 10.15bn | 10.19bn | 9.86bn | 9.51bn | 8.81bn | 8.47bn | 8.54bn |
| Shares outstanding | 1.25bn | 1.25bn | 1.26bn | 1.27bn | 1.28bn | 1.28bn | 1.29bn | 1.30bn |
| Shares issued | 1.25bn | 1.25bn | 1.26bn | 1.27bn | 1.28bn | 1.28bn | 1.29bn | 1.30bn |
| Treasury shares | 1.71bn | 1.71bn | 1.70bn | 1.69bn | 1.67bn | 1.67bn | 1.66bn | 1.65bn |
| — |
| — |
| 94m |
| Share-based compensation | 97m | 89m | 97m | 87m | 82m | 80m |
| Capital expenditure | — | — | 185m | — | — | 111m |
| Investing cash flow | — | — | −186m | — | — | −111m |
| Dividends paid | — | — | 292m | — | — | 261m |
| Share buybacks | — | — | 976m | — | — | 997m |
| Financing cash flow | — | — | −1.28bn | — | — | −1.26bn |